| 1 |
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology
|
4 Feb 2006 |
1,141 |
| 2 |
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Wolfgang Hueber et al. · Science Translational Medicine
|
6 Oct 2010 |
868 |
| 3 |
International Classification of Retinopathy of Prematurity, Third Edition
Michael F. Chiang et al. · Ophthalmology
Open access |
8 Jul 2021 |
822 |
| 4 |
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Robert L. Avery, Joel A. Pearlman, Dante J. Pieramici et al. · Ophthalmology
|
Oct 2006 |
803 |
| 5 |
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA
Open access |
13 Nov 2015 |
779 |
| 6 |
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman, Neil M. Bressler, Haijing Qin et al. · Ophthalmology
Open access |
Apr 2011 |
573 |
| 7 |
Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
Yosef Koronyo, David Biggs, Ernesto Barrón et al. · JCI Insight
Open access |
16 Aug 2017 |
537 |
| 8 |
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Quan Dong Nguyen et al. · Ophthalmology
|
20 Sep 2010 |
533 |
| 9 |
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Jeffrey S. Heier et al. · The Lancet
Open access263 authors |
Oct 2023 |
509 |
| 10 |
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. Fernando Arévalo, Maurício Maia, Harry W. Flynn et al. · British Journal of Ophthalmology
|
26 Oct 2007 |
410 |
| 11 |
A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration
Amir H. Kashani, JANE S. LEBKOWSKI, Firas M. Rahhal et al. · Science Translational Medicine
|
4 Apr 2018 |
396 |
| 12 |
Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
Robert L. Avery, ALESSANDRO A. CASTELLARIN, Nathan C. Steinle et al. · British Journal of Ophthalmology
Open access |
7 Jul 2014 |
382 |
| 13 |
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
Robert L. Avery, ALESSANDRO A. CASTELLARIN, Nathan C. Steinle et al. · Retina
Open access |
19 Jan 2017 |
355 |
| 14 |
Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab
Peter A. Campochiaro, Raafay Sophie, Joel A. Pearlman et al. · Ophthalmology
Open access |
7 Oct 2013 |
354 |
| 15 |
ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)
Jonathan Shahar, Robert L. Avery, Gad Heilweil et al. · Retina
|
27 Feb 2006 |
354 |
| 16 |
REGRESSION OF RETINAL AND IRIS NEOVASCULARIZATION AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
Robert L. Avery · Retina
|
27 Feb 2006 |
344 |
| 17 |
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui‐Shuang Ying, Jiayan Huang, Maureen G. Maguire et al. · Ophthalmology
Open access |
6 Oct 2012 |
314 |
| 18 |
Modified Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema
Carol M. Lee, R. Joseph Olk · Ophthalmology
|
Oct 1991 |
312 |
| 19 |
Visual Results after Surgical Removal of Subfoveal Choroidal Neovascular Membranes
Matthew A. M. Thomas, John D. Dickinson, Nancy S. Melberg et al. · Ophthalmology
|
Aug 1994 |
307 |
| 20 |
Punctate Inner Choroidopathy
Robert C. Watzke, Andrew J. Packer, James C. Folk et al. · American Journal of Ophthalmology
|
Nov 1984 |
285 |
| 21 |
INTRAVITREAL INJECTION TECHNIQUE AND MONITORING
Robert L. Avery, Sophie J. Bakri, Mark Scott Blumenkranz et al. · Retina
|
Dec 2014 |
272 |
| 22 |
Surgical Management of Subfoveal Choroidal Neovascularization
Matthew A. Thomas, M. Gilbert Grand, David F. Williams et al. · Ophthalmology
|
Jun 1992 |
260 |
| 23 |
Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement
Adam S. Hassan, Mark W. Johnson, Todd E. Schneiderman et al. · Ophthalmology
|
Oct 1999 |
260 |
| 24 |
INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
Melvin Rabena, Dante J. Pieramici, ALESSANDRO A. CASTELLARIN et al. · Retina
|
30 Mar 2007 |
245 |
| 25 |
Deep learning versus human graders for classifying diabetic retinopathy severity in a nationwide screening program
Paisan Ruamviboonsuk et al. · npj Digital Medicine
Open access |
10 Apr 2019 |
234 |
| 26 |
Nuclear Sclerotic Cataract after Vitrectomy in Patients Younger than 50 Years of Age
Nancy S. Melberg, M.A. Thomas · Ophthalmology
|
Oct 1995 |
226 |
| 27 |
Systemic Safety of Prolonged Monthly Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
Robert L. Avery, Gabriel M. Gordon · JAMA Ophthalmology
Open access |
29 Oct 2015 |
220 |
| 28 |
Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment
Susan B. Bressler, Allison R. Ayala, Neil M. Bressler et al. · JAMA Ophthalmology
Open access |
11 Jan 2016 |
217 |
| 29 |
The Expanded Spectrum of Focal Choroidal Excavation
Ron Margolis · Archives of Ophthalmology
|
14 Jun 2011 |
216 |
| 30 |
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
Zongzhong Tong et al. · Proceedings of the National Academy of Sciences
Open access |
5 May 2008 |
209 |
| 31 |
MACULAR HOLE SURGERY WITHOUT FACE-DOWN POSITIONING
Paul E. Tornambe, LON S. POLINER, KURT GROTE · Retina
|
May 1997 |
190 |
| 32 |
Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience
Anne L. Peters, Antonio P. Legorreta, R. Clifford Ossorio et al. · Diabetes Care
|
Jun 1996 |
188 |
| 33 |
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
Nancy M. Holekamp, Peter A. Campochiaro, MARGARET A. CHANG et al. · Ophthalmology
Open access |
29 Sep 2021 |
185 |
| 34 |
Surgical Removal of Subfoveal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome
M.A. Thomas, Henry J. Kaplan · American Journal of Ophthalmology
|
1991 |
183 |
| 35 |
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab
André J. Witkin, Paul Hahn, Timothy G. Murray et al. · Journal of VitreoRetinal Diseases
Open access |
Jul 2020 |
182 |
| 36 |
Vitrectomy for Premacular Fibroplasia
Samuel R. Pesin, R. Joseph Olk, M. Gilbert Grand et al. · Ophthalmology
|
Jul 1991 |
182 |
| 37 |
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
Arshad M. Khanani, Aamir A Aziz, Hannah Khan et al. · Eye
Open access |
12 May 2023 |
181 |
| 38 |
Modified Grid Argon (Blue-Green) Laser Photocoagulation for Diffuse Diabetic Macular Edema
R. Joseph Olk · Ophthalmology
|
Jul 1986 |
181 |
| 39 |
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema
David M. Brown, Andrés Emanuelli, Francesco Bandello et al. · American Journal of Ophthalmology
Open access |
14 Jan 2022 |
172 |
| 40 |
Change in Diabetic Retinopathy Through 2 Years
Susan B. Bressler, Danni Liu, Adam R. Glassman et al. · JAMA Ophthalmology
Open access |
27 Apr 2017 |
164 |
| 41 |
Sequential Unmasking: A Means of Minimizing Observer Effects in Forensic DNA Interpretation
Dan E. Krane, Simon Ford, Jason R. Gilder et al. · Journal of Forensic Sciences
Open access |
Jul 2008 |
161 |
| 42 |
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
Glenn J. Jaffe, Thomas A. Ciulla, Antonio Pasquale Ciardella et al. · Ophthalmology
Open access |
28 Oct 2016 |
150 |
| 43 |
Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments
Chandrakumar Balaratnasingam, Lawrence A. Yannuzzi, Christine A. Curcio et al. · Investigative Ophthalmology & Visual Science
Open access |
19 Oct 2016 |
148 |
| 44 |
Vitrectomy for Prevention of Macular Holes
Serge de Bustros et al. · Ophthalmology
Open access |
Jun 1994 |
134 |
| 45 |
Surgical Management of Submacular Hemorrhage
Hector E. Ibanez · Archives of Ophthalmology
|
1995 |
134 |
| 46 |
Idiopathic Retinitis, Vasculitis, Aneurysms, and Neuroretinitis (IRVAN)
Michael Samuel, Robert A. Equi, Tom Chang et al. · Ophthalmology
|
Aug 2007 |
134 |
| 47 |
ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)
MONICA GIGANTI, Paul M. Beer, Nicole Lemanski et al. · Retina
|
2010 |
132 |
| 48 |
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
Peter A. Campochiaro, Robert L. Avery, David M. Brown et al. · The Lancet
|
27 Mar 2024 |
129 |
| 49 |
Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration
Philip J. Rosenfeld, Pravin U. Dugel, Frank Gerhard Holz et al. · Ophthalmology
Open access |
30 Apr 2018 |
124 |
| 50 |
INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR REFRACTORY PSEUDOPHAKIC CYSTOID MACULAR EDEMA
John O. Mason, Michael A. Albert, Rachel S. Vail · Retina
|
27 Feb 2006 |
120 |